Incremental prognostic value of a novel metabolite‐based biomarker score in congestive heart failure patients
Abstract Aims The Cardiac Lipid Panel (CLP) is a newly discovered panel of metabolite‐based biomarkers that has shown to improve the diagnostic value of N terminal pro B type natriuretic peptide (NT‐proBNP). However, little is known about its usefulness in predicting outcomes. In this study, we deve...
Main Authors: | Peter McGranaghan, Hans‐Dirk Düngen, Anshul Saxena, Muni Rubens, Joseph Salami, Jasmin Radenkovic, Doris Bach, Svetlana Apostolovic, Goran Loncar, Marija Zdravkovic, Elvis Tahirovic, Jovan Veskovic, Stefan Störk, Emir Veledar, Burkert Pieske, Frank Edelmann, Tobias Daniel Trippel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12928 |
Similar Items
-
Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure
by: Peter McGranaghan, et al.
Published: (2021-04-01) -
Lipid Metabolite Biomarkers in Cardiovascular Disease: Discovery and Biomechanism Translation from Human Studies
by: Peter McGranaghan, et al.
Published: (2021-09-01) -
Stroke Genomics: Current Knowledge, Clinical Applications and Future Possibilities
by: Sandeep Appunni, et al.
Published: (2022-02-01) -
Obstetric outcomes during delivery hospitalizations among obese pregnant women in the United States
by: Muni Rubens, et al.
Published: (2022-04-01) -
Trends in quality of primary care in the United States, 2007–2016
by: Anshul Saxena, et al.
Published: (2022-02-01)